239 related articles for article (PubMed ID: 25937461)
1. A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.
Velligan DI; Roberts D; Mintz J; Maples N; Li X; Medellin E; Brown M
Schizophr Res; 2015 Jul; 165(2-3):175-80. PubMed ID: 25937461
[TBL] [Abstract][Full Text] [Related]
2. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms.
Li Y; Li WX; Zou YM; Yang ZY; Xie DJ; Yang Y; Lui SSY; Strauss GP; Cheung EFC; Chan RCK
Schizophr Res; 2018 Dec; 202():248-253. PubMed ID: 29996973
[TBL] [Abstract][Full Text] [Related]
4. Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.
Wójciak P; Rybakowski J
Psychiatr Pol; 2018 Apr; 52(2):185-197. PubMed ID: 29975360
[TBL] [Abstract][Full Text] [Related]
5. Issues in selection of instruments to measure negative symptoms.
Daniel DG
Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
[TBL] [Abstract][Full Text] [Related]
7. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
8. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
[TBL] [Abstract][Full Text] [Related]
9. Motivational deficits as the central link to functioning in schizophrenia: a pilot study.
Foussias G; Mann S; Zakzanis KK; van Reekum R; Remington G
Schizophr Res; 2009 Dec; 115(2-3):333-7. PubMed ID: 19836211
[TBL] [Abstract][Full Text] [Related]
10. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
Engel M; Lincoln TM
Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
[TBL] [Abstract][Full Text] [Related]
11. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
Engel M; Lincoln TM
Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
[TBL] [Abstract][Full Text] [Related]
12. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
Mach C; Dollfus S
Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
[TBL] [Abstract][Full Text] [Related]
13. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
14. Anticipatory pleasure and approach motivation in schizophrenia-like negative symptoms.
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2013 Dec; 210(2):422-6. PubMed ID: 23928213
[TBL] [Abstract][Full Text] [Related]
15. Defining and measuring negative symptoms of schizophrenia in clinical trials.
Marder SR; Kirkpatrick B
Eur Neuropsychopharmacol; 2014 May; 24(5):737-43. PubMed ID: 24275698
[TBL] [Abstract][Full Text] [Related]
16. Emotional episodes in the everyday lives of people with schizophrenia: the role of intrinsic motivation and negative symptoms.
McCormick BP; Snethen G; Lysaker PH
Schizophr Res; 2012 Dec; 142(1-3):46-51. PubMed ID: 23022211
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
[TBL] [Abstract][Full Text] [Related]
20. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
